EGFR-IN-58
EGFR-IN-58 (Compound 4a) is a potent, ATP-competitive, and selective EGFR inhibitor. EGFR-IN-58 shows potent cytotoxicity against melanoma, colon, and blood cancers[1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-58.html
Solubility
10 mM in DMSO
Smiles
CN1CCN(CC1)C2=CC=C(C=C2)NC(C3=CN=CN=C3NC4=CC5=C(N(C=C5)CC6=CC(F)=CC=C6)C=C4)=O
Molecular Formula
C31H30FN7O
Molecular Weight
535.61
References & Citations
[1]Ahmed Karam Farag, et al. Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors. Bioorg Chem. 2022 Sep;126:105918.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6468843-01 0.1 mL
Cholinergic receptor, nicotinic, beta 2 (CHRNB2, Acrb2, N-alpha 1, Neuronal acetylcholine receptor non-alpha-1 chain, Neuronal acetylcholine receptor subunit beta-2) (APC)
Ask
View Details MBS6468843-02 5x 0.1 mL
Cholinergic receptor, nicotinic, beta 2 (CHRNB2, Acrb2, N-alpha 1, Neuronal acetylcholine receptor non-alpha-1 chain, Neuronal acetylcholine receptor subunit beta-2) (APC)
Ask
View Details 
QP6153-ec-1mg 1mg
Recombinant Human Histone deacetylase 6 Protein, His-SUMO, E.coli-1mg
Ask
View Details